SYNCOM FORMULATIONS (INDIA) LTD. - Board Meeting Intimation for Consideration And Approval Of The Standalone And Consolidated Un-Audited Quarter And Nine Months Ended Financial Results Quarter Ended 31St December, 2022.

SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve 1. the Standalone and Consolidated Un-audited Quarter and Nine Months ended Financial Results of the Company for the Quarter and Nine Months ended on 31st December, 2022. 2. Limited Review Report by the Statutory Auditors for Financial Results of the company for the Quarter and Nine Months ended on 31st December, 2022. 3. And other Routine Business.